Stockscreener 앱 받기
0.00
100.00%
-0.0111
전일 마감가:
$0.0111
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$N/A
수익:
$547.00K
순이익/손실:
$-34.02M
주가수익비율:
0.00
EPS:
-47.04
순현금흐름:
$-27.11M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
+221.67%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$1.15
Trevena Inc Stock (TRVN) Company Profile
Compare TRVN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRVN
Trevena Inc
|
0.00 | 0 | 547.00K | -34.02M | -27.11M | -47.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Trevena Inc Stock (TRVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-15 | 개시 | Oppenheimer | Perform |
| 2020-09-14 | 개시 | Guggenheim | Buy |
| 2020-08-28 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-05-31 | 재개 | H.C. Wainwright | Buy |
| 2018-11-05 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2018-10-12 | 다운그레이드 | Needham | Buy → Hold |
| 2018-10-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2017-11-08 | 재확인 | Needham | Buy |
| 2017-10-16 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2017-10-12 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-08 | 재확인 | Needham | Buy |
| 2017-02-23 | 재확인 | H.C. Wainwright | Buy |
| 2017-02-22 | 재확인 | FBR & Co. | Outperform |
| 2017-02-02 | 개시 | Ladenburg Thalmann | Buy |
| 2017-01-09 | 개시 | H.C. Wainwright | Buy |
| 2017-01-05 | 개시 | Oppenheimer | Outperform |
| 2016-05-17 | 재확인 | FBR Capital | Outperform |
| 2016-05-17 | 재확인 | Needham | Buy |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2015-09-01 | 재확인 | Wedbush | Outperform |
| 2015-08-03 | 개시 | Brean Capital | Buy |
모두보기
Trevena Inc 주식(TRVN)의 최신 뉴스
Novakand Pharma applies for Nasdaq's approval of continued listing - marketscreener.com
S&P 500, Nasdaq turn negative; S&P down 0.4%, Nasdaq falls 0.9% - marketscreener.com
Trevena (NASDAQ:TRVN) Share Price Passes Above Fifty Day Moving Average – Should You Sell? - Defense World
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - The Manila Times
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: - GlobeNewswire
What technical patterns form on Trevena Inc. (6T4) stock chartsJuly 2025 Market Mood & Fast Entry and Exit Trade Plans - bollywoodhelpline.com
Critical Contrast: Ampio Pharmaceuticals (NYSE:AMPE) vs. Trevena (NASDAQ:TRVN) - Defense World
Trevena Restructures China Royalty Rights to Exit Debt - TipRanks
Trevena Signs Assignment and Release Agreement With R-Bridge Investment Four and Jiangsu Nhwa Pharmaceutical - TradingView — Track All Markets
Trevena (NASDAQ:TRVN) Shares Cross Below Fifty Day Moving Average – Here’s What Happened - Defense World
How Trevena Inc. (6T4) stock valuation compares with sectorQuarterly Portfolio Review & Risk Managed Investment Entry Signals - ulpravda.ru
Analyst Upgrade: How Trevena Inc. (6T4) stock benefits from digital adoptionJuly 2025 Action & Long Hold Capital Preservation Tips - ulpravda.ru
Published on: 2026-01-09 03:04:06 - ulpravda.ru
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors - MEXC
Published on: 2026-01-09 00:14:30 - ulpravda.ru
RMTICurrent Report Filing (8-k) - ADVFN
Trevena Inc. (TRVN) Stock Price | Live Quotes & Charts | EXPM - StocksToTrade
Critical Review: Vincerx Pharma (NASDAQ:VINC) & Trevena (NASDAQ:TRVN) - Defense World
Cash per share of Trevena, Inc. – BER:6T4 - TradingView — Track All Markets
Why Trevena Inc 6T4 stock stays undervaluedRisk Management & Low Drawdown Trading Techniques - moha.gov.vn
EBIT per share of Trevena, Inc. – MUN:6T4 - TradingView — Track All Markets
Will Trevena Inc. (6T4) stock outperform small cap peersWeekly Trade Recap & Community Verified Trade Signals - Newser
Is Trevena Inc. (6T4) stock undervalued by metricsJuly 2025 PreEarnings & Long-Term Investment Growth Plans - Newser
Can Trevena Inc. (6T4) stock reach $200 price targetJuly 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - Newser
How Trevena Inc. (6T4) stock reacts to new regulations2025 Geopolitical Influence & Weekly High Momentum Picks - Newser
Why Trevena Inc. (6T4) stock is favored by hedge fundsWeekly Profit Report & Fast Gain Stock Tips - Newser
Will Trevena Inc. (6T4) stock deliver stable dividends2025 Pullback Review & Advanced Technical Analysis Signals - Newser
Will Trevena Inc. (6T4) stock extend growth storyMarket Performance Report & Precise Buy Zone Tips - Newser
Smood Sweets Redefines Better-for-You Candy with Launch of "Candy Dates" – Joined by Entrepreneur and Actor Oliver Trevena - Nosh.com
Cash per share of Trevena, Inc. – MUN:6T4 - TradingView
P 500 performance this yearJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
What downside risks could hit Trevena Inc. (6T4) stockWeekly Trade Review & Trade Opportunity Analysis Reports - newser.com
How Trevena Inc. (6T4) stock stacks up against competitorsWeekly Trend Recap & Verified Stock Trade Ideas - newser.com
Is Trevena Inc. (6T4) stock a top pick for value investors2025 Support & Resistance & Verified Swing Trading Watchlists - newser.com
Why Trevena Inc. (6T4) stock could outperform next yearPortfolio Value Summary & Weekly Watchlist of Top Performers - newser.com
Is Trevena Inc. (6T4) stock suitable for passive index funds2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com
Trevena Inc (TRVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
0.87%
자본화:
|
볼륨(24시간):